New research is calling for further study on a possible link between COVID-19 jabs and long-term vision issues.

(Reuters) -British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after ...

Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks ...

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.